Specify Company / Ticker to Get the Summary
Dividend History ANIP
Dividend Analytics ANIP
Max Ratio
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–ANI Pharmaceuticals Inc
ANIPANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota. Address: 210 Main Street West, Baudette, MN, United States, 56623
Analytics
WallStreet Target Price
81.17 USDP/E Ratio
–Dividend Yield
–Financials ANIP
Results | 2019 | Dynamics |